Wellington Management Group LLP Tg Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 73,320 shares of TGTX stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,320

Previous 65,071 12.68%

Holding current value

$2.21 Million

Previous $1.16 Million 48.14%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $141,965 - $208,534	8,249 Added 12.68%	73,320 $1.71 Million
Q2 2024 Aug 13, 2024	SELL	$13.32 - $19.19 $41.1 Million - $59.3 Million	-3,088,522 Reduced 97.94%	65,071 $1.16 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $41.1 Million - $67.2 Million	3,153,593 New	3,153,593 $48 Million
Q4 2023 Feb 12, 2024	BUY	$6.68 - $18.81 $21 Million - $59.1 Million	3,139,764 New	3,139,764 $53.6 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $527,833 - $1.67 Million	-63,138 Reduced 2.0%	3,096,474 $25.9 Million
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $2.61 Million - $5.91 Million	-168,739 Reduced 5.07%	3,159,612 $78.5 Million
Q1 2023 May 12, 2023	SELL	$10.23 - $19.34 $1.08 Million - $2.03 Million	-105,099 Reduced 3.06%	3,328,351 $50.1 Million
Q4 2022 Feb 13, 2023	SELL	$5.01 - $11.83 $4.95 Million - $11.7 Million	-988,672 Reduced 22.36%	3,433,450 $40.6 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $1.07 Million - $1.97 Million	234,678 Added 5.6%	4,422,122 $26.2 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $624,460 - $1.78 Million	166,968 Added 4.15%	4,187,444 $17.8 Million
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $1.8 Million - $4.71 Million	-230,194 Reduced 5.42%	4,020,476 $38.2 Million
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $40.7 Million - $95 Million	2,674,941 Added 169.76%	4,250,670 $80.8 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $58.2 Million - $108 Million	-2,671,948 Reduced 62.9%	1,575,729 $52.4 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $2.25 Million - $3.38 Million	-69,084 Reduced 1.6%	4,247,677 $165 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $25 Million - $32.6 Million	-601,072 Reduced 12.22%	4,316,761 $208 Million
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $40.7 Million - $88.4 Million	1,610,787 Added 48.71%	4,917,833 $256 Million
Q3 2020 Nov 16, 2020	BUY	$18.49 - $27.24 $61.1 Million - $90.1 Million	3,307,046 New	3,307,046 $88.5 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

87.7M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.37B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Tg Therapeutics, Inc. Transaction History